Strictly speaking, JAMA Oncology actually ended the old year (in its issue on December 29, 2016), rather than beginning the new one, with two articles, a letter to the editor, and an editorial that deal with two of the more controversial issues that affect the way we think about the management of prostate cancer. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: androgen, controversy, deprivation, IADT, intermitten, metastasis, risk, screening | 2 Comments »
THE "NEW" PROSTATE CANCER INFOLINK 